13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 44 holding rows worth $68,326,000.
- Accession
- 0001389933-13-000010
- Filer
- CIK 1389933
- Filed
- 2013-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2013
A holdings report, 44 entries on the cover page, a total value of $68,326,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $68,326,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PHARMACYCLICS INC | 716933106 | COM | 102,128 | $8,116,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 461,362 | $6,210,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 477,701 | $4,538,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 868,106 | $4,262,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 124,981 | $3,926,000 | thousands by filing date | |
| INSULET CORP | 45784PAC5 | CNV | 3,000,000 | $3,911,000 | thousands by filing date | principal |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 251,654 | $3,594,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 191,215 | $3,344,000 | thousands by filing date | |
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 1,733,660 | $2,635,000 | thousands by filing date | |
| CARDIONET INC | 14159L103 | COM | 401,788 | $2,371,000 | thousands by filing date | |
| GIVEN IMAGING LTD | M52020100 | ORD | 156,320 | $2,190,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 578,381 | $2,001,000 | thousands by filing date | |
| CURIS INC | 231269101 | COM | 549,896 | $1,754,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 715,200 | $1,581,000 | thousands by filing date | |
| CARDICA INC | 14141R101 | COM | 1,063,469 | $1,180,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 121,800 | $996,000 | thousands by filing date | |
| NUVASIVE INC | 670704AC9 | CORPORATE OBLIG | 1,000,000 | $986,000 | thousands by filing date | principal |
| SPECTRANETICS CORP | 84760C107 | COM | 52,362 | $978,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 191,262 | $947,000 | thousands by filing date | |
| VENAXIS INC | 92262A107 | COM | 697,000 | $836,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $807,000 | thousands by filing date | |
| BAXANO SURGICAL | 071773105 | COM | 336,351 | $807,000 | thousands by filing date | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 51,692 | $806,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 90,947 | $791,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 88,694 | $781,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 57,009 | $761,000 | thousands by filing date | |
| INFUSYSTEM HOLDINGS INC | 45685K102 | COMMON STOCK | 474,484 | $707,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 8,600 | $689,000 | thousands by filing date | |
| EXACTECH INC | 30064E109 | COM | 33,636 | $664,000 | thousands by filing date | |
| RTI BIOLOGICS INC | 74975N105 | COM | 167,058 | $628,000 | thousands by filing date | |
| UROPLASTY INC | 917277204 | COM NEW | 289,332 | $599,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 106,993 | $598,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 77,000 | $575,000 | thousands by filing date | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 79,834 | $452,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 10,000 | $448,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 17,500 | $371,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 221,508 | $343,000 | thousands by filing date | |
| THERAGENICS CORP | 883375107 | COM | 160,719 | $333,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 514,768 | $319,000 | thousands by filing date | |
| GRAYMARK HEALTHCARE INC | 389465303 | COM | 693,027 | $146,000 | thousands by filing date | |
| CYCLACEL PHARMACEUTICALS INC | 23254L306 | COM | 44,300 | $131,000 | thousands by filing date | |
| AUTHENTIDATE HLDG CORP | 052666203 | COM | 142,062 | $124,000 | thousands by filing date | |
| DIGIRAD CORP | 253827109 | COM | 36,672 | $89,000 | thousands by filing date | |
| COMBIMATRIX CORP | 20009T121 | *W EXP 05/01/201 | 2,325 | $1,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-13-000010 | this filing | 2013-08-14 | acceptance time not in the bulk data set |